Gynuity Health Projects, New York, NY 10010, USA.
BJOG. 2011 Jan;118(1):17-23. doi: 10.1111/j.1471-0528.2010.02753.x. Epub 2010 Nov 23.
To test the feasibility and efficacy of an approach that foregoes the routine use of ultrasound for the determination of eligibility for medical termination of pregnancy.
Prospective trial.
Ten termination of pregnancy clinics in the USA.
A total of 4484 women seeking termination of pregnancy with mifepristone-misoprostol.
Women provided estimates of the date of their last menstrual period and underwent pelvic bimanual and ultrasound examinations. We compared estimates of gestational age using these three methods.
Proportion of women of ≤9 weeks' gestation by woman or provider estimate, but >9 weeks' gestation by ultrasound.
The reliance on women's report of their last menstrual period together with physical examination to determine their eligibility for termination of pregnancy with mifepristone-misoprostol would result in few women (63/4008 or 1.6%) accepted for treatment outside the current limits of standard mifepristone-misoprostol regimens used for early termination of pregnancy (i.e. ≤63 days' gestation on ultrasound).
Last menstrual period and physical examination alone, without the routine use of ultrasound, are highly effective for the determination of women's eligibility for early termination of pregnancy with mifepristone-misoprostol.
测试一种方法的可行性和疗效,该方法避免常规使用超声来确定是否有资格进行药物流产终止妊娠。
前瞻性试验。
美国的 10 家流产诊所。
共 4484 名接受米非司酮-米索前列醇药物流产的妇女。
女性提供其末次月经日期的估计值,并进行盆腔双合诊和超声检查。我们比较了这三种方法估计的胎龄。
通过女性或提供者估计为≤9 周妊娠,但超声检查为>9 周妊娠的女性比例。
仅依靠女性报告其末次月经和体格检查来确定其是否有资格接受米非司酮-米索前列醇药物流产,将导致少数女性(63/4008 或 1.6%)接受超出目前标准米非司酮-米索前列醇早期流产方案(即超声检查<63 天)的治疗。
仅依靠末次月经和体格检查,而不常规使用超声,对于确定女性是否有资格接受米非司酮-米索前列醇药物流产非常有效。